Triphasil-21
NDC Package 0008-2535-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Triphasil-21 is a . Marketed by Wyeth Pharmaceuticals Llc, A Subsidiary Of Pfizer Inc., this product is identified by NDC 0008-2535 and is authorized under FDA application NDA019192.

Identification & Billing

NDC Package Code
0008-2535-01
Package Description
3 DIALPACK in 1 PACKAGE / 1 KIT in 1 DIALPACK
Product Code
0008-2535
11-Digit Billing Format
00008253501

Clinical Specifications

Proprietary Name
Triphasil-21
Dosage Form
-

Regulatory & Marketing

Labeler Name
Wyeth Pharmaceuticals Llc, A Subsidiary Of Pfizer Inc.
FDA Application #
NDA019192
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
12-01-1984
End Marketing Date
02-29-2008
Listing Expiration
02-29-2008
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0008-2535-01 identifies a specific commercial package of 3 dialpack in 1 package / 1 kit in 1 dialpack of Triphasil-21, labeled by Wyeth Pharmaceuticals Llc, A Subsidiary Of Pfizer Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Wyeth Pharmaceuticals Llc, A Subsidiary Of Pfizer Inc. on December 01, 1984. The current certification is valid through February 29, 2008.

How is this Wyeth Pharmaceuticals Llc, A Subsidiary Of Pfizer Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00008253501. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0008-2535-01
11-Digit CMS (5-4-2)
00008-2535-01

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.